Pulmonary Cancer

In this month’s “Hot Topic,” Anja Roden, M.D., discusses new entities and changes of terminology in the 2021 World Health Organization (WHO) classification of lung tumors as well as the nomenclature in small biopsies.

By MCL Education • November 1, 2021

In this month’s “Hot Topic,” Anja Roden, M.D., will discuss the role of PD-L1 interaction in the immune system, challenges with PD-L1 testing, and current PD-L1 testing in Non-Small Cell Lung Carcinoma (NSCLC).

By MCL Education • November 9, 2020

In this month’s “Hot Topic,” Anja Roden, M.D., discusses mesothelial proliferations, their challenges, and which ancillary testing might help to overcome some of those challenges.

By MCL Education • August 3, 2020

Kevin Halling, M.D., gives an overview of the lung cancer NGS panel available through Mayo Clinic Laboratories. He discusses when this testing should be ordered, how this testing compares to previous testing approaches, and what clinical action can be taken due to the results of this testing.

By Alyssa Frank • June 26, 2020

This “Specialty Testing” webinar discusses changes introduced in the 8th edition of the AJCC lung cancer staging manual.

By MCL Education • June 13, 2018